Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management

This, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeutic targets such as EMT, cancer stem cells, and the tumor microenvironment; current personalized clinical manageme...

Full description

Corporate Author: SpringerLink (Online service)
Other Authors: Ahmad, Aamir. (Editor, http://id.loc.gov/vocabulary/relators/edt), Gadgeel, Shirish M. (Editor, http://id.loc.gov/vocabulary/relators/edt)
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2016.
Edition:1st ed. 2016.
Series:Advances in Experimental Medicine and Biology, 890
Subjects:
Online Access:https://doi.org/10.1007/978-3-319-24932-2
LEADER 02758nam a22004695i 4500
001 978-3-319-24932-2
003 DE-He213
005 20210616024512.0
007 cr nn 008mamaa
008 151224s2016 gw | s |||| 0|eng d
020 |a 9783319249322  |9 978-3-319-24932-2 
024 7 |a 10.1007/978-3-319-24932-2  |2 doi 
050 4 |a RC261-271 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
082 0 4 |a 614.5999  |2 23 
245 1 0 |a Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management  |h [electronic resource] /  |c edited by Aamir Ahmad, Shirish M. Gadgeel. 
250 |a 1st ed. 2016. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2016. 
300 |a X, 231 p. 22 illus., 21 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Advances in Experimental Medicine and Biology,  |x 0065-2598 ;  |v 890 
520 |a This, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeutic targets such as EMT, cancer stem cells, and the tumor microenvironment; current personalized clinical management and radiation therapy for lung cancers; and the promise of epigenetics and next-generation sequencing for the advancements towards personalized therapy of lung cancer patients. With chapters on state-of-the-art therapies and technologies written by leading experts working to develop novel companion diagnosis tools for the personalized treatment of lung cancer patients, this volume brings readers up-to-date by presenting the current knowledge on the efforts to make personalized management of lung cancer patients a reality. . 
650 0 |a Cancer research. 
650 1 4 |a Cancer Research.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/B11001 
700 1 |a Ahmad, Aamir.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Gadgeel, Shirish M.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783319249315 
776 0 8 |i Printed edition:  |z 9783319249339 
776 0 8 |i Printed edition:  |z 9783319797021 
830 0 |a Advances in Experimental Medicine and Biology,  |x 0065-2598 ;  |v 890 
856 4 0 |u https://doi.org/10.1007/978-3-319-24932-2 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)